Accidental hydroxyurea overdosage in a child with sickle cell anemia: An African experience
- 2 August 2020
- journal article
- letter
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 67 (10), e28632
- https://doi.org/10.1002/pbc.28632
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Effectiveness and Safety of Hydroxyurea in the Treatment of Sickle Cell Anaemia Children in Jos, North Central NigeriaJournal of Tropical Pediatrics, 2020
- Current perspectives of sickle cell disease in Nigeria: changing the narrativesExpert Review of Hematology, 2019
- Prospective longitudinal follow‐up of children with sickle cell disease treated with hydroxyurea since infancyPediatric Blood & Cancer, 2019
- Hydroxyurea for Children with Sickle Cell Anemia in Sub-Saharan AfricaThe New England Journal of Medicine, 2019
- Novel use Of Hydroxyurea in an African Region with Malaria (NOHARM): a trial for children with sickle cell anemiaBlood, 2017
- Degree of anemia, indirect markers of hemolysis, and vascular complications of sickle cell disease in AfricaBlood, 2017
- From Infancy to AdolescenceMedicine, 2014
- Emerging science of hydroxyurea therapy for pediatric sickle cell diseasePediatric Research, 2013
- Current sickle cell disease management practices in NigeriaInternational Health, 2013
- Hydroxyurea Therapy Reduces Mortality Among Children with Sickle Cell DiseaseBlood, 2010